Combined therapy (intravitreal bevacizumab plus verteporfin photodynamic therapy) versus intravitreal bevacizumab monotherapy for choroidal neovascularization due to age-related macular degeneration: a 1-year follow-up study

Lignende værker

• Combined therapy with bevacizumab and photodynamic therapy for myopic choroidal neovascularization:A one-year follow-up controlled study
  af: Sandro Saviano, et al.
  Udgivet: (2014-04-01)
• Combined therapy with bevacizumab and photodynamic therapy for myopic choroidal neovascularization: A one-year follow-up controlled study
  af: Saviano, Sandro, et al.
  Udgivet: (2014)
• Verteporfin photodynamic therapy combined with intravitreal triamcinolone for choroidal neovascularization due to angioid streaks
  af: Pece, Alfredo, et al.
  Udgivet: (2010)
• A prospective study on different methods for the treatment of choroidal neovascularization. The efficacy of verteporfin photodynamic therapy, intravitreal bevacizumab and transpupillary thermotherapy in patients with neovascular age-related macular degeneration
  af: Nowak, Michał S., et al.
  Udgivet: (2012)
• Combined intravitreal bevacizumab and photodynamic therapy with vertiporfin for management of choroidal neovascularization secondary to age-related macular degeneration
  af: Kabeel, Mamdouh M, et al.
  Udgivet: (2008)